TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Neurotech International ( (AU:NTI) ) has issued an announcement.
Neurotech International Ltd has announced its corporate governance framework for the financial year ending June 30, 2025, in alignment with the ASX Corporate Governance Principles and Recommendations. The company has adopted a comprehensive set of governance policies, including a Board Charter, Risk Management Policy, and Anti-Bribery Policy, reflecting its commitment to transparency and integrity. This governance structure is tailored to the company’s current size and nature, with provisions for future expansion as operations grow in scale and complexity, ensuring robust oversight and strategic direction.
More about Neurotech International
Neurotech International Ltd operates in the biotechnology industry, focusing on developing medical solutions and technologies. The company is involved in creating products that cater to neurological conditions, aiming to improve patient outcomes and enhance quality of life.
Average Trading Volume: 811,694
Technical Sentiment Signal: Sell
Current Market Cap: A$13.65M
For an in-depth examination of NTI stock, go to TipRanks’ Overview page.